Literature DB >> 12764022

Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases.

Shakil A Khan1, Michel W Skaf, Robert W Harrison, Kwangho Lee, Khalid M Minhas, Anil Kumar, Mike Fradley, Artin A Shoukas, Dan E Berkowitz, Joshua M Hare.   

Abstract

The mechanisms by which nitric oxide (NO) influences myocardial Ca2+ cycling remain controversial. Because NO synthases (NOS) have specific spatial localization in cardiac myocytes, we hypothesized that neuronal NOS (NOS1) found in cardiac sarcoplasmic reticulum (SR) preferentially regulates SR Ca2+ release and reuptake resulting in potentiation of the cardiac force-frequency response (FFR). Transesophageal pacing (660 to 840 bpm) in intact C57Bl/6 mice (WT) stimulated both contractility (dP/dtmax normalized to end-diastolic volume; dP/dt-EDV) by 51+/-5% (P<0.001) and lusitropy (tau; tau) by 20.3+/-2.0% (P<0.05). These responses were markedly attenuated in mice lacking NOS1 (NOS1-/-) (15+/-2% increase in dP/dt-EDV; P<0.001 versus WT; and no change in tau; P<0.01 versus WT). Isolated myocytes from NOS1-/- (approximately 2 months of age) also exhibited suppressed frequency-dependent sarcomere shortening and Ca2+ transients ([Ca2+]i) compared with WT. SR Ca2+ stores, a primary determinant of the FFR, increased at higher frequencies in WT (caffeine-induced [Ca2+]i at 4 Hz increased 107+/-23% above 1 Hz response) but not in NOS1-/- (13+/-26%; P<0.01 versus WT). In contrast, mice lacking NOS3 (NOS3-/-) had preserved FFR in vivo, as well as in isolated myocytes with parallel increases in sarcomere shortening, [Ca2+]i, and SR Ca2+ stores. NOS1-/- had increased SR Ca2+ ATPase and decreased phospholamban protein abundance, suggesting compensatory increases in SR reuptake mechanisms. Together these data demonstrate that NOS1 selectively regulates the cardiac FFR via influences over SR Ca2+ cycling. Thus, there is NOS isoform-specific regulation of different facets of rate-dependent excitation-contraction coupling; inactivation of NOS1 has the potential to contribute to the pathophysiology of states characterized by diminished frequency-dependent inotropic responses.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12764022     DOI: 10.1161/01.RES.0000078171.52542.9E

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  69 in total

1.  Upregulation of arginase-II contributes to decreased age-related myocardial contractile reserve.

Authors:  Mehnaz Khan; Jochen Steppan; Karl H Schuleri; Karl Schuleri; Sungwoo Ryoo; Eric Tuday; Lukasz Bugaj; Lakshmi Santhanam; Tal Berkowitz; Daniel Nyhan; Artin A Shoukas; Dan E Berkowitz
Journal:  Eur J Appl Physiol       Date:  2011-12-08       Impact factor: 3.078

2.  NO and superoxide: opposite ends of the seesaw in cardiac contractility.

Authors:  Joseph Bonaventura; Andrew Gow
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

3.  Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function.

Authors:  Farideh Beigi; Daniel R Gonzalez; Khalid M Minhas; Qi-An Sun; Matthew W Foster; Shakil A Khan; Adriana V Treuer; Raul A Dulce; Robert W Harrison; Roberto M Saraiva; Courtney Premer; Ivonne Hernandez Schulman; Jonathan S Stamler; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-24       Impact factor: 11.205

4.  Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S-nitrosylation.

Authors:  Honglan Wang; Serge Viatchenko-Karpinski; Junhui Sun; Inna Györke; Nancy A Benkusky; Mark J Kohr; Héctor H Valdivia; Elizabeth Murphy; Sandor Györke; Mark T Ziolo
Journal:  J Physiol       Date:  2010-06-07       Impact factor: 5.182

5.  Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.

Authors:  Vaibhav B Patel; Abhijit Takawale; Tharmarajan Ramprasath; Subhash K Das; Ratnadeep Basu; Maria B Grant; David A Hall; Zamaneh Kassiri; Gavin Y Oudit
Journal:  J Mol Med (Berl)       Date:  2015-04-15       Impact factor: 4.599

Review 6.  NO/redox disequilibrium in the failing heart and cardiovascular system.

Authors:  Joshua M Hare; Jonathan S Stamler
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

7.  The fork in the nitric oxide road: cyclic GMP or nitrosylation?

Authors:  Mark T Ziolo
Journal:  Nitric Oxide       Date:  2008-02-08       Impact factor: 4.427

8.  Mechanisms associated to impaired activity of cardiac P-type ATPases in endothelial nitric oxide synthase knockout mice.

Authors:  Daniele C Rezende; Elisa S C Pôças; Humberto Muzi-Filho; Valéria M N Cunha; Afonso Caricati-Neto; Aron Jurkiewicz; François Noël; Luis E M Quintas
Journal:  J Physiol Biochem       Date:  2012-08-09       Impact factor: 4.158

9.  Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling.

Authors:  Shakil A Khan; Kwangho Lee; Khalid M Minhas; Daniel R Gonzalez; Shubha V Y Raju; Ankit D Tejani; Dechun Li; Dan E Berkowitz; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-14       Impact factor: 11.205

10.  Partial restoration of cardiac function with ΔPDZ nNOS in aged mdx model of Duchenne cardiomyopathy.

Authors:  Yi Lai; Junling Zhao; Yongping Yue; Nalinda B Wasala; Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2014-01-25       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.